Page 3 - Round Financing News Today

Worldcoin was conceived in 2019 and relies on basketball-size devices that scan irises to create a unique identifier for each user.

Tech hub saw 70% drop in funding in the first quarter and underperformed worldwide average

Altruist has raised more than $290 million since it was founded by Jason Wenk in 2018.

At-home fitness company’s latest funding round was completed at fraction of prior valuation

Character.AI says it raised $150 million from Andreessen Horowitz and others

nd-6 th, 2021, Viva Biotech successfully hosted the 2021 Partnership Summit. Over 300 attendees joined the Summit, including representatives from global investment institutions, R&D heads from pharmaceutical companies, and business development leaders. As one of the largest annual events held by Viva, the Partnership Summit is committed to gathering the leading forces from the scientific research community, bio pharmaceutical industry, capital groups and more to assist biotech start-ups in ach...

Starling Bank nets £272m in late-stage funding led by Fidelity and Qatari investor Starling says it’s still profitable, having exceeded £1.5m in net income every month since October Anne Boden, CEO of Starling Bank has been adamant that the bank will not entertain offers of being acquired itself, after it was reported that JPMorgan and Lloyds Banking Group had made their interest in the scaleup known Getty Images By Monday March 8, 2021 7:31 am British digital challenge...

Jan. 12, 2021 7:13 pm ET Centricity Inc., a startup that uses artificial intelligence to help companies predict consumer demand for specific products in particular communities, is expected to raise $10 million in new venture-capital money this year. The New York City-based company, one of many enterprise technology startups that have gained traction during the pandemic, uses AI algorithms to analyze some 2.5 billion data points’ worth of internet traffic a day to predict demand for ...

The $450m funding round means Checkout has raised more than $830m in less than two years

Order Reprints Print Article A pharmaceutical start-up that thinks it can undersell the entire drug industry got off to a quick start in its first year in business, grabbing rights to a handful of drugs, including two that could make it a player in the hottest cancer drug market sometime in the next few years. Now comes the hard part: Getting doctors to prescribe its cheap drugs, instead of brand-name competitors backed by big marketing budgets. On... Close A Start-Up That Wants to Un...